Cargando…
Response to "Pharmacovigilance 2030: Invited Commentary for the January 2020 ‘Futures’ Edition"
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383961/ https://www.ncbi.nlm.nih.gov/pubmed/32196646 http://dx.doi.org/10.1002/cpt.1812 |
| _version_ | 1783563525524815872 |
|---|---|
| author | Hauben, Manfred Gregory, William W. Caubel, Patrick |
| author_facet | Hauben, Manfred Gregory, William W. Caubel, Patrick |
| author_sort | Hauben, Manfred |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7383961 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73839612020-07-28 Response to "Pharmacovigilance 2030: Invited Commentary for the January 2020 ‘Futures’ Edition" Hauben, Manfred Gregory, William W. Caubel, Patrick Clin Pharmacol Ther Perspectives John Wiley and Sons Inc. 2020-03-20 2020-07 /pmc/articles/PMC7383961/ /pubmed/32196646 http://dx.doi.org/10.1002/cpt.1812 Text en © 2020 The Authors. Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Perspectives Hauben, Manfred Gregory, William W. Caubel, Patrick Response to "Pharmacovigilance 2030: Invited Commentary for the January 2020 ‘Futures’ Edition" |
| title | Response to "Pharmacovigilance 2030: Invited Commentary for the January 2020 ‘Futures’ Edition" |
| title_full | Response to "Pharmacovigilance 2030: Invited Commentary for the January 2020 ‘Futures’ Edition" |
| title_fullStr | Response to "Pharmacovigilance 2030: Invited Commentary for the January 2020 ‘Futures’ Edition" |
| title_full_unstemmed | Response to "Pharmacovigilance 2030: Invited Commentary for the January 2020 ‘Futures’ Edition" |
| title_short | Response to "Pharmacovigilance 2030: Invited Commentary for the January 2020 ‘Futures’ Edition" |
| title_sort | response to "pharmacovigilance 2030: invited commentary for the january 2020 ‘futures’ edition" |
| topic | Perspectives |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383961/ https://www.ncbi.nlm.nih.gov/pubmed/32196646 http://dx.doi.org/10.1002/cpt.1812 |
| work_keys_str_mv | AT haubenmanfred responsetopharmacovigilance2030invitedcommentaryforthejanuary2020futuresedition AT gregorywilliamw responsetopharmacovigilance2030invitedcommentaryforthejanuary2020futuresedition AT caubelpatrick responsetopharmacovigilance2030invitedcommentaryforthejanuary2020futuresedition |